Status:
COMPLETED
Diagnosis of Invasive Pulmonary Aspergillosis (IPA) in Critically Ill Patients
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Survival After IPA
Risk Factors for IPA
Eligibility:
All Genders
18+ years
Brief Summary
Invasive pulmonary aspergillosis (IPA) is difficult to diagnose and remains a cause of high morbidity and mortality in critically ill patients in the ICU. Accepted diagnostic protocols for haemato-onc...
Detailed Description
Invasive pulmonary aspergillosis (IPA) is difficult to diagnose and remains a cause of high morbidity and mortality in critically ill patients in the ICU. The number of patients with positive Aspergil...
Eligibility Criteria
Inclusion
- \> 18 years
- positive aspergillus culture in respiratory tract sample OR
- positive aspergillus galactomannan in respiratory tract sample
Exclusion
- no inform consent
- age \< 18 years
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT01866020
Start Date
January 1 2013
End Date
January 1 2015
Last Update
May 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Hamburg-Eppendorf
Hamburg, Hamburg, Germany, 20246